Elite in Ocular Hypertension (OHT)

Luciano Quaranta

Via Flero 36, 
Brescia, IT 
Elite in Ocular Hypertension (OHT)
Via Flero 36, 
Brescia, IT 
OverviewLocationsClinical Research

Overview

Luciano Quaranta practices in Brescia, Italy. Mr. Quaranta is rated as an Elite expert by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Pigment-Dispersion Syndrome, Glaucoma, Ocular Hypertension (OHT), Trabeculectomy, and Vitrectomy.

His clinical research consists of co-authoring 104 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 81 articles in the study of Ocular Hypertension (OHT).

Gender
Male

Locations

Via Flero 36, Brescia, 25123, Italy
Other Locations
Pavia, Italy
Via Olgettina 60, Milan, 20136, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene
Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene
Enrollment Status: Completed
Publish Date: November 29, 2023
A Prospective, Observer-masked, Randomized Clinical Trial to Investigate and Compare the Clinical Efficacy of Chloroprocaine 3% Gel and Tetracaine 0.5% Eye Drop as Topical Anestheticsin Phacoemulsification.
A Prospective, Observer-masked, Randomized Clinical Trial to Investigate and Compare the Clinical Efficacy of Chloroprocaine 3% Gel and Tetracaine 0.5% Eye Drop as Topical Anestheticsin Phacoemulsification.
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

104 Total Publications

Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies.
Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies.
Journal: Advances in therapy
Published: March 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Quaranta's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile